Host Microbe Core
宿主微生物核心
基本信息
- 批准号:10237340
- 负责人:
- 金额:$ 20.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-06 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAnimal ModelAnimalsAntibioticsAreaAttentionBacteriaBacteroidesBiochemicalBiological AssayBiologyCellsCellular biologyClinicalClinical MicrobiologyClinical ResearchCollaborationsCommunitiesConsultationsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDiseaseDisease OutcomeEndocrineEndocrine systemEpithelialEquipmentEscherichia coliEvolutionExperimental DesignsFosteringFunctional disorderGastrointestinal tract structureGenomicsGoalsGrowthHistocytochemistryHistopathology FacilityImageImmuneImmune responseImmunohistochemistryIn Situ HybridizationIn VitroInflammationInflammatoryInflammatory ResponseInfrastructureInvestigationKidneyLaboratoriesLife ExpectancyLinkLiverLungMalignant NeoplasmsMeasuresMethodsMicrobeMicrobiologyMicroscopyMorbidity - disease rateMucous MembraneNational Institute of Diabetes and Digestive and Kidney DiseasesOrganOutcomePancreasPathogenesisPathologicPathologyPharmaceutical PreparationsPhenotypePilot ProjectsProteomeProteomicsReagentRenal functionReproducibilityResearchResearch PersonnelResearch SupportResourcesRespiratory SystemRoleSamplingServicesSlideSpecialistSpecimenSuggestionSurfaceTechniquesTissuesTrainingTranslational ResearchWorkairway epitheliumbasebehavioral studybody systemboneclinically relevantcystic fibrosis patientsdesigndigital imagingdigital pathologydigital repositoriesexperienceexperimental studygastrointestinalgut microbiotaimprovedinnovationinterestmetabolomemicrobialmicrobial hostmicrobiomemicrobiome componentsnext generationnovelpathogenpre-clinical researchprogramsranpirnasetargeted imagingtooltranscriptometranslational approachtreatment responsevaccine response
项目摘要
ABSTRACT
The Host Microbe Core (HMC) will assist and support the research base, trainees, and pilot project
investigators by providing specimens, reagents, training, and services to define both the microbial and host
response determinants of CF diseases in organs and tissues prioritized by the NIDDK. This Core combines the
resources and expertise of specialists in CF basic and clinical microbiology, airway epithelial and immune cell
biology, pathology, and microscopy to provide an integrated network of services, reflecting an evolution in the
field of CF disease pathogenesis to concurrently investigate the host and pathogens. Core services available
to the UW CF P30 research base include:
1. Technical assistance and state-of-the-art facilities for histopathology, immunohistochemistry, in situ
hybridization and localization of host and microbial targets, and digital imaging
2. Quantitative digital pathology and whole slide digital repository for pancreata and lungs from people
with CF
3. Processing clinical, animal, and laboratory specimens for microbiome, proteome, metabolome, and
transcriptome analyses, and for specific targets
4. Microbial culturing of CF specimens in formats representative of CF mucosal conditions for phenotypic,
proteomic, genomic, and biochemical analyses
5. Access to strains of bacteria cultured from CF clinical fecal samples, including Escherichia coli and
Bacteroides spp.
6. Consultation and training in methods provided by the Core and experimental design
7. Interacting closely with the Clinical and Genomics cores to provide unified services for CF researchers
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lucas R Hoffman其他文献
Lucas R Hoffman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lucas R Hoffman', 18)}}的其他基金
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease
以患者为中心的微生物组和先进的培养方法来识别慢性儿科疾病的微生物决定因素
- 批准号:
10400043 - 财政年份:2018
- 资助金额:
$ 20.73万 - 项目类别:
Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease
以患者为中心的微生物组和先进的培养方法来识别慢性儿科疾病的微生物决定因素
- 批准号:
9915962 - 财政年份:2018
- 资助金额:
$ 20.73万 - 项目类别:
The relationship of fecal microbiomes and nutritional status in CF
CF患者粪便微生物群与营养状况的关系
- 批准号:
9349480 - 财政年份:2014
- 资助金额:
$ 20.73万 - 项目类别:
The relationship of fecal microbiomes and nutritional status in CF
CF患者粪便微生物组与营养状况的关系
- 批准号:
8815576 - 财政年份:2014
- 资助金额:
$ 20.73万 - 项目类别:
The relationship of fecal microbiomes and nutritional status in CF
CF患者粪便微生物群与营养状况的关系
- 批准号:
9134726 - 财政年份:2014
- 资助金额:
$ 20.73万 - 项目类别:
The relationship of fecal microbiomes and nutritional status in CF
CF患者粪便微生物群与营养状况的关系
- 批准号:
8929222 - 财政年份:2014
- 资助金额:
$ 20.73万 - 项目类别:
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational Study
铜绿假单胞菌早期 CF 适应性变化:一项转化研究
- 批准号:
8598103 - 财政年份:2011
- 资助金额:
$ 20.73万 - 项目类别:
Pseudomonas aeruginosa early CF adaptive changes: A translational study
铜绿假单胞菌早期 CF 适应性变化:一项转化研究
- 批准号:
8027435 - 财政年份:2011
- 资助金额:
$ 20.73万 - 项目类别:
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational Study
铜绿假单胞菌早期 CF 适应性变化:一项转化研究
- 批准号:
8213594 - 财政年份:2011
- 资助金额:
$ 20.73万 - 项目类别:
Pseudomonas Aeruginosa Early CF Adaptive Changes: A Translational Study
铜绿假单胞菌早期 CF 适应性变化:一项转化研究
- 批准号:
8403705 - 财政年份:2011
- 资助金额:
$ 20.73万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 20.73万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 20.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 20.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 20.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 20.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 20.73万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 20.73万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 20.73万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 20.73万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 20.73万 - 项目类别:
Discovery Grants Program - Individual